Distribution of CTX-M β-lactamase genes among Escherichia coli strains isolated from patients in Iran

Laboratory Medicine

Volumn 40, Issue 12, 2009, Pages 724-727

  Mirzaee, Mohsen ^a   Owlia, Parviz ^b   Mansouri, Sadegh ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBENICILLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLA CTX M GENE; DNA EXTRACTION; ESCHERICHIA COLI; GENE IDENTIFICATION; IRAN; MULTIPLEX POLYMERASE CHAIN REACTION;

ESCHERICHIA COLI;

EID: 77951968708     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/LMUUWBHMZEDYTBW5     Document Type: Article

References (33)

1. Jesús R, Maria DN, Luisa R, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol. 2004;42:1089-1094.
2. Canton R, Novais A, Valverde A, et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008;14:144-153. (Pubitemid 350269194)
3. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-951.
4. Oteo J, Navarro C, Cercenado E, et al. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol. 2006;44:2359-2366. (Pubitemid 44092399)
5. Pagani L, Dell'Amico E, Migliavacca R, et al. Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol. 2003;41:4264-4269. (Pubitemid 37099694)
6. Alobwede I, M'Zali FH, Livermore DM, et al. CTX-M extended-spectrum beta-lactamase arrives in the UK. J Antimicrob Chemother. 2003;51:470-471.
7. Brenwald NP, Jevons G, Andrews JM, et al. An outbreak of a CTX-M-type beta-lactamase producing Klebsiella pneumoniae: The importance of using cefpodoxime to detect extended-spectrum beta-lactamases. J Antimicrob Chemother. 2003;51:195-196. (Pubitemid 36163857)
8. Munday CJ, Whitehead GM, Todd NJ, et al. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. J Antimicrob Chemother. 2004;54:628-633.
9. Woodford N, Fagan EJ, and Ellington MJ. Development of multiplex PCR assay for genes encoding CTX-M extended-spectrum beta-lactamases. Clin Microbiol Infect. 2005;11:121-126.
10. Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection. 1990;18:294-348. (Pubitemid 20349311)
11. Bauernfeind A, Casellas JM, Goldberg M. A new plasmidic cefotaximase from patients infected with Salmonellatyphimurium. Infection. 1992;20:158-163.
12. Bernard H, Tancrede C, Livrelli V, et al. A novel plasmid-mediated extended-spectrum β-lactamase not derived from TEM or SHV-type enzymes. Antimicrob Agents Chemother. 1992;29:590-592.
13. Lucia P, Bartoloni A, Fiorelli C, et al. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother. 2007;51:2720-2725. (Pubitemid 47206205)
14. Mirzaee M, Pourmand MR, Chitsaz M, et al. Antibiotic resistance to third generation cephalosporins due to CTX-M-type extended-spectrum β-Lactamases in clinical isolates of Escherichia coli. Iranian J Pub Health. 2009;38:10-17.
15. Baraniak A, Fiett J, Hryniewicz W, et al. Ceftazidimehydrolyzing CTXM-15 extended-spectrum β-lactamase (ESBL) in Poland. Antimicrob Agents Chemother. 2002;50:393-396.
16. Pitout JD, Nordmann P, Laupland KB, et al. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. Antimicrob Agents Chemother. 2005;56:52-59. (Pubitemid 41418336)
17. Baron EJ, Finegold SM. Bailey and Scott's Diagnostic Microbiology. 8th ed. St Louis, MO: CV Mosby Company; 1990.
18. NCCLS. Performance standards for antimicrobial susceptibility testing. 12th informational supplement. NCCLS document M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
19. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved NCCLS document M7-A5. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
20. Schwaber MJ, Raney PM, Raney PM, et al. Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J Clin Microbiol. 2004;42:294-298.
21. Johnson A, Woodford N. Plasmid analysis. In: Johnson A, Woodford P, eds. Molecular Bacteriology Protocols and Clinical Application. London: Human Press; 1998:24-28.
22. Bonnet R. Growing group of extended-spectrum betalactamases: The CTX-M enzymes. Antimicrob Agents Chemother. 2004;48:1-14. (Pubitemid 38040170)
23. Winokur PL, Canton R, Casellas JM, et al. Variations in the prevalence of strains expressing an extended-spectrum β-Lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clin Infe Dis. 2001;32:94-103. (Pubitemid 32424264)
24. Mehrgan H, Rahbar M. Prevalence of extended-spectrum beta-lactamase- producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Internat'l J Antimicrob Agents Chemother. 2008;31:147-151.
25. Lautenbach E, Strom BL, Bilker WB, et al. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis. 2001;33:1288-1294. (Pubitemid 32955176)
26. Edelstein M, Pimkin M, Palagin I, et al. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Animicrob Agent Chemoter. 2003;47:3724-3732. (Pubitemid 37484979)
27. Randegger CC, Hachler H. Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 2001;45:1730-1736. (Pubitemid 32466341)
28. Kader AA, Angamuthu K. Prevalence and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med. 2005;25:239-242. (Pubitemid 40959776)
29. Sanguinetti M, Posteraro B, Ciccaglione D, et al. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix Extended-Spectrum β-Lactamase Detection Method. J Clin Microbiol. 2003;41:1463-1468. (Pubitemid 36428090)
30. Lartigue MF, Zinsius C, Wenger A, et al. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother. 2007;51:2855-2860. (Pubitemid 47206222)
31. Lavigne, JP, Marchandin H, Delmas J, et al. qnrA in CTX-M producing Escherichia coli isolates from France. Antimicrob Agents Chemother. 2006;50:4224-4228.
32. Eisner A, Fagan EJ, Feierl G, et al. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum beta-lactamase in Austria. Antimicrob Agents Chemother. 2006;50:785-787.
33. Pitout, JD, Hossain DA, Hanson ND. Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol. 2004;42:5715-5721.